![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 28, 2018 10:50:39 PM
can't help think the FDA has just thought of a reason t o deny out of thin air. Is there a check box for gender in the application form?
did the data for other studies actually have gender recorded?
Can't imagine how to market a back pain solution just for women, the public will think they are crazy.
Should have been cleared but with some strict labelling requirements which would state that "this product has been shown to work better for women, men benefitted but to a lesser degree" or something similar.
thats what labelling is for.
but because the predicate studies didn't show any deviation they cant be used.. that is complete FDA obstructionism and their senators should get involved.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM